OfferAn FDA-first for skin cancer

DermaSensor

at Crowdability · New York City

Details.

An FDA-first for skin cancer. Medical devices and equipment company raising $1.235 million at a $72.4 million valuation.

Oxeia Biopharma

A solution for millions who suffer

ACME Atronomatic

Weather forecasts that are actually accurate

Hexxco

Taking hydrogen power mainstream

bluShift Aerospace

Fueling the next space race

rHEALTH

A space-age medical device

Sonical

AI for your ears

Get the app to claim this offer and see what else is on nearby.